Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : World Outlook -- Ignore unavailable to you. Want to Upgrade?

To: bull_dozer who wrote (50890)	1/19/2026 12:04:00 AM
From: bull_dozer	Read Replies (1) \| Respond to of 51069

To: bull_dozer who wrote (50890)	1/19/2026 12:59:07 AM
From: ajtj99	1 Recommendation Recommended By bull_dozer Read Replies (1) \| Respond to of 51069

That's just nonsense. They're not going to stop insulin exports. They're not going to stop selling Ozempic because they'll lose market share. Lastly, Maersk is a US flagged carrier, which allows it to carry cargo for the US military globally. That's not going to end. No other US flagged carrier can do what they do.

To: bull_dozer who wrote (50890)	1/19/2026 8:56:05 AM
From: Les H	Read Replies (1) \| Respond to of 51069

Insulin Exports The global insulin export market is a significant sector, with the United States being the largest exporter, holding over 50% of the global share. In 2024, the US exported 3,466 kilograms of insulin globally, with the market size reaching $11.56 billion. The top three exporters of human insulin are India, the United States, and Germany, with India leading the world in exports. The US insulin market is dominated by three companies: Eli Lilly and Company (U.S.), Novo Nordisk A/S (Denmark), and Sanofi S.A. (France), which supply the US market as well. Novo Nordisk does manufacture insulin in Denmark. The company has a significant presence in Kalundborg, where it produces around 50% of the world's insulin. Novo Nordisk's production facilities in Denmark are a cornerstone of its global production network, contributing to its status as one of the largest producers of insulin in the world.